Details of the Drug
General Information of Drug (ID: DMAM3OH)
| Drug Name |
SUN-E3001
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
CHS-13340; PTH[1,34], Suntory; RhPTH(1-34); RhPTH[1,34], Daiichi Asubio Pharma; Recombinant human parathyroid hormone[residues 1-34] (osteoporosis), Asubio Pharma; RhPTH[1,34] (osteporosis), Asubio Pharma
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| ICD Disease Classification | 15 Disease of the musculoskeletal system/connective tissue | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Disease Class | ICD-11: FA20 Rheumatoid arthritis | |||||||||||||||||||||||
| The Studied Tissue | Bone marrow | |||||||||||||||||||||||
| The Studied Disease | Osteoporosis [ICD-11:FA20] | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References

